On January 29, Nasdaq reported its fourth quarter and full year 2024 earnings. Nasdaq’s results reflected a year of strong financial and operational performance as well as strategic execution across ...
About This EventNovocure (Nasdaq: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback